Market Insights
Gall bladder diseases afflict a significant number of people on a regular basis. In 2013 more than 100 million people were diagnosed with gallbladder and related diseases which resulted in more than 100,000 deaths. The gall bladder is a vital organ which stores bile produced by the liver and pass it along a duct which then empties into the small intestine. Market Research Future has dedicated valuable resources to the research of the global gall bladder treatment market. Calculation regarding market growth reveals a CAGR of 6.5% during the forecast period between 2017 and 2023. The market is expected to reach an evaluation of USD 27,121.5 Mn by the end of 2023.
Get Latest Free Sample copy Available @ https://www.marketresearchfuture.com/sample_request/3945
The biggest driver of the gall bladder treatment market is the increasing prevalence of gall bladder diseases caused primarily by a sedentary lifestyle and/or poor lifestyle habits. Aggressive alcohol abuse or poor eating habits are likely to trigger gall bladder diseases. The increasing prevalence of gall bladder disease has resulted in increased awareness with regards to gall bladder diseases and treatment and has driven high demand for effective gall bladder treatment. The adoption of advanced diagnostic has also encouraged the demand for advanced treatment options which are minimally invasive. Moreover, the presence of a large and rapidly growing geriatric population is expected to have a significant impact on the market in a positive manner. Emerging economies are prime regions for the expansion of the market, and they display high opportunity for growth during the forecast period.
Despite healthy growth during the forecast period, the complications and pain associated with gall bladder surgery and recovery, combined with the asymptomatic nature of gallstones will likely slow market growth during the assessment period.
GallBladder Treatment Market Segmentation
The global Gallbladder Treatment Market Revenue is segmented on the basis of disease indication, diagnosis, treatment, end-users, and region. On the basis of disease indication the global gall bladder treatment market has been segmented into gallbladder polyps, gallbladder cancer, cholecystitis & biliary colic, gall stone, and cholelithiasis & choledocholithiasis. Gallstones make up 24.5% of the total share of the market making the gallstones segment the largest segment.
Diagnosis has been segmented into computerized tomography (CT), ultrasound, blood tests, and cholangiography & hepatobiliary scintigraphy. The ultrasound segment is captured maximum market share. However, the CT segment is projected to witness growth at a CAGR of 7.10% during the review period.
Treatment has been divided between surgery and drugs. Surgery accounts for the most significant share of the market by treatment and is expected to reach a substantial market value by the end of 2023.
End-users include hospitals & gynecology clinics, and academic & research centers.
GallBladder Treatment Market Regional Analysis
North America has reached the forefront of the global gall bladder treatment market due to the presence of a significant patient population which is afflicted by gall bladder disease. In North America, the U.S holds the largest market share. Developed economies tend to have a higher prevalence of gallbladder diseases. Europe is the second largest regional market for gall bladder treatment. The presence of a developed healthcare sector and high healthcare expenditure has secured Europe its leading market position. Meanwhile, the Asia Pacific is growing in prominence as a regional market in the global market for gall bladder treatment. Awareness regarding gall bladder disease and the increased demand for treatments as well as the presence of a massive patient population is expected to drive the APAC market. APAC is expected to grow at a CAGR of 7.0% during the review period.
GallBladder Treatment Market Key Players
Dornier MedTech, Boston Scientific Corporation, B. Braun Melsungen AG, Sanofi, Intuitive Surgical, Koninklijke Philips N.V., C. R. Bard, Inc. and others have been identified and included in MRFR's analysis of the competition in the global gall bladder treatment market.
Browse Complete Report With Toc @ https://www.marketresearchfuture.com/reports/gallbladder-treatment-market-3945
Related Reports Links:-
https://www.marketresearchfuture.com/reports/yeast-infection-market-4228
https://www.marketresearchfuture.com/reports/anti-ageing-drugs-market-3504
https://www.marketresearchfuture.com/reports/non-destructive-medical-technologies-market-4396
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team has the supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics, and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay
updated with the technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
